Responses
Other responses
Jump to comment:
- Published on: 29 April 2016
- Published on: 29 April 2016
- Published on: 29 April 2016Author's replyShow More
Dear Editor
I thank Mishra and colleagues for their cogent comments about the potential clinical utility of ELISPOT for diagnosis of tuberculosis infection in high burden countries, such as India.[1]
The high prevalence of latent tuberculosis infection in Indian adults [2] means that ELISPOT (as with any test of tuberculosis infection, as opposed to active disease) cannot be used to routinely ‘rule in’ a...
Conflict of Interest:
None declared. - Published on: 29 April 2016Use of ELISPOT for latent tuberculosis: utility in countries with a high burden of infection.Show More
Dear Editor
We read with interest your article for detection of latent tuberculosis.[1]
As the author has pointed out, this test is perhaps more useful for those countries with a low burden of infection. However, even then, it is surprising that there is only one study on Indian subjects.[2] Using this test, the authors recorded a 80% prevalence for latent tuberculosis in healthy adult Indians, compared t...
Conflict of Interest:
None declared.